Mkts

10x Genomics, Inc.

NASDAQ: TXG
$51.80-5.58 (-9.72%)
As of Nov 20, 9:30 AM ET

Key statistics

Day range
51.3056.44
52-week range
15.18102.81
Today
Open55.77
Previous close51.80
Volume3.23M
Valuation
Market cap7.21B
P/E ratio—
EPS (TTM)-0.52
Income & risk
Dividend / yield—
Beta2.10
Avg volume2.55M
Discussion

TXG News

Stories mentioning TXG from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue150,843166,030149,002172,908154,883165,021151,654153,104
Cost of Goods Sold44,66552,98548,69547,82449,43854,06645,26148,884
Gross Profit106,178113,045100,307125,084105,445110,955106,393104,220
Operating Expenses
Research & Development
Sales General & Admin66,37776,61775,35574,43489,72893,82681,70483,039
Total Operating Expenses123,224132,586132,54994,958144,773160,794147,878145,957
Operating Income (Loss)(17,046)(19,541)(32,242)30,126(39,328)(49,839)(41,485)(41,737)
Interest Income5,0146,8925,1994,2713,6864,5084,9714,715
Interest Expense
Other Expense(815.00)(2,544)(1,165)2,6032,136(3,049)2,078(56.00)
Pretax Income(12,847)(15,193)(28,205)36,997(33,506)(48,380)(34,438)(37,079)
Tax Provision623.001,059(733.00)2,459852.00648.001,315818.00
Net Income (Loss)(13,470)(16,252)(27,472)34,538(34,358)(49,028)(35,753)(37,897)
Earnings Per Share (Basic)(0.10)(0.13)(0.22)0.28(0.28)(0.41)(0.30)(0.32)
Earnings Per Share (Diluted)(0.10)(0.13)(0.22)0.28(0.28)(0.41)(0.30)(0.32)
Weighted Average Shares Outstanding (Basic)128,291124,750125,502123,755122,606120,452120,733120,067
Weighted Average Shares Outstanding (Diluted)128,291124,750125,502124,510122,606120,452120,733120,067

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About TXG

10x Genomics, Inc. (NASDAQ: TXG) is a stock listed on the Nasdaq Stock Market under the ticker symbol TXG. It last traded at $51.80 (Nov 20, 2026, 9:30 AM ET), down 9.7% on the day. That gives 10x Genomics a market capitalisation of $7.2B.

Over the past 52 weeks TXG has traded between $15.18 and $102.81.

Revenue for the quarter ended Mar 31, 2026 was $150.8M; a net loss of $13.5M. Revenue was down 2.6% from $154.9M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$150.8M-$13.5M-8.9%
Dec 31, 2025$166.0M-$16.3M-9.8%
Sep 30, 2025$149.0M-$27.5M-18.4%
Jun 30, 2025$172.9M$34.5M20.0%

From 10x Genomics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…